Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solitary Kidney”

1,419 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,419 results

Early research (Phase 1)Study completedNCT05497297
What this trial is testing

Evaluate the Pharmacokinetics of HSK7653 in Subjects With Renal Impairment

Who this might be right for
Renal Impairment
Haisco Pharmaceutical Group Co., Ltd. 42
Not applicableNot Yet RecruitingNCT07130448
What this trial is testing

The Relation of Albumin/Globulin Ratio and Platelet/Albumin Ratio to Lupus Nephritis

Who this might be right for
Lupus Nephritis (LN)SLE - Systemic Lupus ErythematosusBiomarkers
Assiut University 120
Not applicableStudy completedNCT07368868
What this trial is testing

Effect of Initiation of Veno-venous ECMO on Urine Output and Acute Kidney Injury

Who this might be right for
ARDS (Acute Respiratory Distress Syndrome)Acute Kidney InjuryECMO
University Hospital, Ghent 76
Testing effectiveness (Phase 2)Study completedNCT03685448
What this trial is testing

ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)

Who this might be right for
Renal Cell CarcinomaPapillary Renal Cell Carcinoma Type 1Papillary Renal Cell Carcinoma Type 2+3 more
Australian and New Zealand Urogenital and Prostate Cancer Trials Group 35
Testing effectiveness (Phase 2)Study completedNCT00556049
What this trial is testing

Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaNeoplasm Metastases
Massachusetts General Hospital 72
Early research (Phase 1)WithdrawnNCT01130623
What this trial is testing

A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors

Who this might be right for
SarcomaNeuroblastomaWilms Tumor+2 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT01818596
What this trial is testing

Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment

Who this might be right for
HIVHIV Infections
Gilead Sciences 252
Early research (Phase 1)Active Not RecruitingNCT07154901
What this trial is testing

Investigation of the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Opemalirsen (AZD2373)

Who this might be right for
Renal Impairment
AstraZeneca 34
Testing effectiveness (Phase 2)Study completedNCT00609401
What this trial is testing

Study Comparing Association Between Sorafenib and Interleukin-2 (IL-2) Versus Sorafenib in 1st Line Therapy in Advanced (Adv) Renal Cell Carcinoma (RCC)

Who this might be right for
Metastatic DiseaseRenal Cell Carcinoma
Italian Trial in Medical Oncology 90
Testing effectiveness (Phase 2)Study completedNCT02607553
What this trial is testing

Safety and Activity of G-202 in Patients With Clear Cell Renal Cell Carcinoma That Expresses PSMA

Who this might be right for
Clear Cell Renal Cell Carcinoma
GenSpera, Inc. 2
Post-approval studies (Phase 4)UnknownNCT03953950
What this trial is testing

Effect of Add-on Spironolactone to Losartan Versus Losartan Alone on Peritoneal Membrane Among Peritoneal Dialysis Patients

Who this might be right for
End Stage Renal DiseasePeritoneal Dialysis
Chiang Mai University 84
Testing effectiveness (Phase 2)UnknownNCT04958473
What this trial is testing

Sintilimab in Combination With Axitinib in Advanced Renal Cell Cancer

Who this might be right for
Renal Cell CarcinomaClear Cell Renal Cell Carcinoma
Tianjin Medical University Second Hospital 40
Post-approval studies (Phase 4)WithdrawnNCT04614142
What this trial is testing

Single Patient Protocol for Donor HCV-positive to Recipient HCV-negative Kidney Transplant in a Patient at Risk for Loss of Dialysis Access

Who this might be right for
End Stage Renal DiseaseChronic Hepatitis c
Massachusetts General Hospital
Early research (Phase 1)Study completedNCT00935831
What this trial is testing

Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment

Who this might be right for
Kidney Disease
GlaxoSmithKline 12
Not applicableStudy completedNCT03446196
What this trial is testing

Hemodynamic Optimization During Single Kidney Transplantation With MostcareUP

Who this might be right for
Transplant Dysfunction
University of Padova 40
Early research (Phase 1)Study completedNCT03252002
What this trial is testing

Clinical Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamic Effects of a Single and Multiple Oral BAY1101042 Tablet Doses in Healthy Male Subjects

Who this might be right for
Healthy Volunteer
Bayer 96
Testing effectiveness (Phase 2)Study completedNCT00211653
What this trial is testing

Acetylcysteine in the Prevention of Renal Failure After Bypass Surgery

Who this might be right for
Kidney Failure
Minneapolis Veterans Affairs Medical Center 102
Early research (Phase 1)Study completedNCT07404137
What this trial is testing

Investigate the Concentrations of Zibotentan and Dapagliflozin in Blood When Given With and Without Food

Who this might be right for
Healthy Participants
AstraZeneca 26
Large-scale testing (Phase 3)Study completedNCT00737477
What this trial is testing

Monthly Subcutaneous (SC) Mircera for Maintenance Treatment of Participants With Chronic Kidney Disease on Peritoneal Dialysis

Who this might be right for
Anemia
Hoffmann-La Roche 96
Early research (Phase 1)Ended earlyNCT04426357
What this trial is testing

Evaluate the Effect of Renal Impairment on JNJ-64417184 and Its Two Minor Metabolites JNJ-68294291 and JNJ-65201526 in Adult Participants

Who this might be right for
Renal Impairment
Janssen Pharmaceutica N.V., Belgium 6
Load More Results